Financial Performance - Net sales for the three months ended March 31, 2025, increased to 727.0million,up6.3684.9 million in the same period of 2024[11] - Gross profit for the nine months ended March 31, 2025, rose to 554.6million,a40.9393.7 million in 2024[11] - Net income for the three months ended March 31, 2025, was 95.4million,significantlyhigherthan6.3 million in the same period of 2024, representing a 1415.9% increase[11] - Earnings per share (EPS) for the three months ended March 31, 2025, were 1.90,comparedto0.12 in 2024, reflecting a substantial increase[11] - Net income for the nine months ended March 31, 2025, was reported at 264.3million,asignificantincreasecomparedto6.3 million for the same period in 2024[20] - The company reported a total comprehensive income of 102.1millionforthethreemonthsendedMarch31,2025,comparedto33.4 million in the same period of 2024[14] - The company’s operating income for the nine months ended March 31, 2025, was 370.4million,upfrom214.8 million in the same period of 2024, marking a 72.5% increase[11] - Basic earnings per common share for the three months ended March 31, 2025, was 1.90,comparedto0.12 for the same period in 2024, reflecting a growth of 1583%[46] - Basic earnings per common share increased to 5.27fortheninemonthsendedMarch31,2025,comparedto1.87 for the same period in 2024, reflecting a growth of 181.8%[46] Assets and Equity - Total assets as of March 31, 2025, amounted to 3,361.8million,anincreasefrom3,291.7 million as of June 30, 2024[9] - Total stockholders' equity increased to 1,781.7millionasofMarch31,2025,comparedto1,628.8 million as of June 30, 2024[9] - As of March 31, 2025, total equity increased to 1,781.7millionfrom1,716.9 million at December 31, 2024, reflecting a growth of approximately 3.8%[18] - Specialty Alloys Operations reported total assets of 2,671.7millionasofMarch31,2025,comparedto2,542.2 million in the previous year, showing a growth of 5.1%[102] - Consolidated total assets for Performance Engineered Products were 427.2millionasofMarch31,2025,aslightdecreasefrom431.5 million in the previous year[102] - Corporate total assets decreased to 265.5millionasofMarch31,2025,downfrom334.8 million in the previous year, a decline of 20.7%[102] Cash Flow and Operating Activities - Net cash provided from operating activities for the nine months ended March 31, 2025, was 182.3million,upfrom105.4 million in 2024[16] - The company reported a decrease in cash and cash equivalents to 151.5millionasofMarch31,2025,downfrom199.1 million at the beginning of the year[16] - Total cash and cash equivalents at the end of the period were 151.5million,upfrom53.5 million at the end of March 2024[16] - The company made cash contributions of 58.5milliontoitspensionplansduringtheninemonthsendedMarch31,2025,comparedto4.9 million in the same period of 2024[51] Capital Expenditures - The company plans to continue investing in property, plant, and equipment, with purchases amounting to 96.3millionfortheninemonthsendedMarch31,2025[16]−CapitalexpendituresforthethreemonthsendedMarch31,2025,were40.2 million, compared to 21.6millioninthesameperiodof2024,indicatingasignificantincreaseof86.096.3 million, up from 68.9millioninthesameperiodof2024,indicatinga39.836.2 million, significantly up from 17.6millioninQ12024,markinga105.72.8 million in Q1 2025 from 3.2millioninQ12024,adeclineof12.51.2 million, up from 0.8millioninQ12024,representinga50454.7 million, up from 391.1millioninthesameperiodof2024,markingagrowthof16.285.0 million, a decrease from 99.6millioninthesameperiodof2024,reflectingadeclineof14.746.4 million in revenue for the three months ended March 31, 2025, compared to 38.7millioninthesameperiodof2024,representinganincreaseofabout20.01,239.6 million, while Medical segment sales were 258.1millionfortheninemonthsendedMarch31,2025[42]−TheUnitedStatesaccountedfor1,273.9 million in total net sales, representing a decrease of 6.0% from 1,150.7millionintheprioryear[42]LiabilitiesandDebt−Long−termdebtasofMarch31,2025,was695.1 million, slightly up from 694.2millionasofJune30,2024[58]−Thecompanyhad348.9 million available under its Credit Facility as of March 31, 2025, with no short-term borrowings[54] - The borrowing rate for the Credit Facility was 6.17% as of March 31, 2025[56] - The company expects to make 6.0millionofrequiredcashpensioncontributionsduringtheremainderoffiscalyear2025[51]−Environmentalremediationliabilitiesrecordedwere17.5 million as of March 31, 2025, slightly up from 17.3millionasofJune30,2024[61]−TheCompanyauthorizedasharerepurchaseprogramofupto400.0 million for its outstanding common stock, with 322.2millionremainingavailableforfuturepurchasesasofMarch31,2025[64]TaxandOtherExpenses−TheeffectivetaxrateforthethreemonthsendedMarch31,2025,was21.826.6 million, compared to 3.8millionforthesameperiodin2024[89]−Thecompanyreportedatotalotherexpense,netof3.8 million for the three months ended March 31, 2025, down from 52.9millioninthesameperiodof2024[86]DerivativeInstrumentsandRiskManagement−Thecompanyrecordedanetgainonderivativeinstrumentsof3.1 million, contributing positively to comprehensive income[20] - The fair value of the Company's derivative financial instruments was 2.1millionasofMarch31,2025,with2.1 million in liabilities[67] - The Company has been designated as a potentially responsible party for certain Superfund sites, but future remediation costs are not expected to materially affect financial position[62] - The Company’s derivative contracts are subject to master netting arrangements, allowing for net settlement, with total asset and liability derivatives both at $2.1 million as of March 31, 2025[77] Miscellaneous - The company plans to adopt new accounting standards related to segment reporting and income tax disclosures, effective for fiscal years beginning after December 15, 2023, and December 15, 2024, respectively[28][29] - The Company has elected to omit disclosure for remaining performance obligations expected to be satisfied in one year or less, streamlining reporting requirements[39] - The company does not anticipate material effects on its financial position from ongoing legal claims and actions[63]